RAKESH KAPOOR

Prof. RAKESH KAPOOR

Radiotherapy & Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
DKDivya Khosla
Divya Khosla
SMShagun Misra
Shagun Misra
PCPek Lim Chu
Pek Lim Chu
PGPeiyong Guan
Peiyong Guan
RNRitambhra Nada
Ritambhra Nada
JHJing Han Hong
Jing Han Hong
Cholangiocarcinomas (CCA) pose a complex challenge in oncology due to diverse etiologies, necessitating tailored therapeutic approaches. This review discusses the risk factors, molecular pathology, and current therapeutic options for CCA and explores the emerging strategies encompassing targeted therapies, immunotherapy, novel compounds from natural sources, and modulation of gut microbiota. CCA are driven by an intricate landscape of genetic mutations, epigenetic dysregulation, and post-transcriptional modification, which differs based on geography (e.g., for liver fluke versus non-liver fluke-driven CCA) and exposure to environmental carcinogens (e.g., exposure to aristolochic acid). Liquid biopsy, including circulating cell-free DNA, is a potential diagnostic tool for CCA, which warrants further investigations. Currently, surgical resection is the primary curative treatment for CCA despite the technical challenges. Adjuvant chemotherapy, including cisplatin and gemcitabine, is standard for advanced, unresectable, or recurrent CCA. Second-line therapy options, such as FOLFOX (oxaliplatin and 5-FU), and the significance of radiation therapy in adjuvant, neoadjuvant, and palliative settings are also discussed. This review underscores the need for personalized therapies and demonstrates the shift towards precision medicine in CCA treatment. The development of targeted therapies, including FDA-approved drugs inhibiting FGFR2 gene fusions and IDH1 mutations, is of major research focus. Investigations into immune checkpoint inhibitors have also revealed potential clinical benefits, although improvements in survival remain elusive, especially across patient demographics. Novel compounds from natural sources exhibit anti-CCA activity, while microbiota dysbiosis emerges as a potential contributor to CCA progression, necessitating further exploration of their direct impact and mechanisms through in-depth research and clinical studies. In the future, extensive translational research efforts are imperative to bridge existing gaps and optimize therapeutic strategies to improve therapeutic outcomes for this complex malignancy.

12 July 2012 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
NKNarendra Kumar
Narendra Kumar
RKRitesh Kumar
Ritesh Kumar
RKRAKESH KAPOOR
RAKESH KAPOOR
SGSushmita Ghoshal
Sushmita Ghoshal
PKPramod Kumar
Pramod Kumar
SSSuresh Chander Sharma
Suresh Chander Sharma

21 May 2020 in International Journal of Applied Positive Psychology
Verified
Journal Article
Closed access
PDF file
AGAtul Kumar Goyal
Atul Kumar Goyal
JBJaimanti Bakshi
Jaimanti Bakshi
NPNaresh K Panda
Naresh K Panda
RKRAKESH KAPOOR
RAKESH KAPOOR
DVDharam Vir
Dharam Vir
SWSumittar Singh Walia
Sumittar Singh Walia

1 August 2014
Verified
Journal Article
Open access
PDF file
VSVijai Simha
Vijai Simha
RKRAKESH KAPOOR
RAKESH KAPOOR
RGRajesh Gupta
Rajesh Gupta
ABAmit Bahl
Amit Bahl
RNRitambhara Nada
Ritambhara Nada
Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?

1 January 2016 in Journal of Contemporary Brachytherapy
Verified
Journal Article
Open access
ABAnshuma Bansal
Anshuma Bansal
SGSushmita Ghoshal
Sushmita Ghoshal
AOArun S Oinam
Arun S Oinam
SSSuresh Chander Sharma
Suresh Chander Sharma
BDBhaswanth Dhanireddy
Bhaswanth Dhanireddy
RKRAKESH KAPOOR
RAKESH KAPOOR
Purpose: To determine outcomes of interstitial high-dose-rate brachytherapy (HDR-BT) in patients with early stage oral tongue cancer. Material and methods : Ninety-two patients with stage I and II oral tongue cancer were treated with HDR-BT between 1999 and 2014: brachytherapy alone = 62...

1 January 2007 in Urologia Internationalis
Verified
Journal Article
Closed access
AMA. Mandhani
A. Mandhani
HCH. Chaudhury
H. Chaudhury
NGN. Gupta
N. Gupta
HSH.K. Singh
H.K. Singh
RKRAKESH KAPOOR
RAKESH KAPOOR
AKAjay Kumar
Ajay Kumar
Introduction: The aim of this study was to assess the efficacy of ureteroscopy for lower ureteric stones without the use of fluoroscopy. Patients andMethods: Between June 2001 and January 2005, a total of 110 patients with a mean age of 33.5 years (range 12–65) suffering from of lower ureteral calculi (below the upper margin of the sacroiliac joint) prospectively underwent ureteroscopic removal. Retrograde pyelography was avoided, and no safety guidewire was placed. Whenever required, the ureteric meatus was dilated with a ureteric balloon under direct vision. Double-J stent placement was done with the aid of ureteroscopy. A fluoroscope was kept standby. The patients had a postoperative X-ray of the kidney-ureter-bladder region to document the stone clearance. Results: The mean stone size was 8.7 mm (range 6–15). Complete clearance without the use of fluoroscopy was achieved in 99 patients (94.2%). Fluoroscopy was required in 6 patients (4%) for calcified stricture (n = 1), duplex system (n = 1), narrow and tortuous meatus causing difficulty in passing the 5-Fr balloon dilator (n = 3), and confirmation of spontaneous passage of the stone (n = 1). Of the 13 patients who required balloon dilatation it was successfully achieved without fluoroscopy. Double-J stenting was done due to mucosal ulceration (n = 3), polypoid reaction (n = 2), and perforation (n = 1). All these patients had correct placement of the stent, as confirmed by X-ray of the kidney-ureter-bladder region postoperatively. Conclusions: To uphold the notion for radiation exposure to be as low as reasonably achievable, ureteroscopic stone retrieval can safely be done without the use of fluoroscopy in a significant number of patients.